Results 311 to 320 of about 213,470 (338)
Some of the next articles are maybe not open access.
Metabolism, 1976
HE HEPATIC PRODUCTION of lipoprotein is a complex phenomenon, involving a synchronous relationship between hepatic apoprotein synthesis, and the actual tipoprotein secretory event. A role for glucagon in modulating these events has been proposed.~ The administration of exogenous glucagon results in a pronounced hypolipemic response in man, dog, fowl ...
openaire +3 more sources
HE HEPATIC PRODUCTION of lipoprotein is a complex phenomenon, involving a synchronous relationship between hepatic apoprotein synthesis, and the actual tipoprotein secretory event. A role for glucagon in modulating these events has been proposed.~ The administration of exogenous glucagon results in a pronounced hypolipemic response in man, dog, fowl ...
openaire +3 more sources
Digestion, 1978
From the mucosa of the gastrointestinal tract a number of peptides can be extracted, which are glucagon-like in their behavior towards antisera raised against the pancreatic hormone. The biochemistry and physiology of these peptides are critically reviewed.
openaire +2 more sources
From the mucosa of the gastrointestinal tract a number of peptides can be extracted, which are glucagon-like in their behavior towards antisera raised against the pancreatic hormone. The biochemistry and physiology of these peptides are critically reviewed.
openaire +2 more sources
Glucagon and Glucagon-Like Peptides 1 and 2
2009The glucagon gene is expressed not only in the alpha cells of the pancreatic islets but also in the endocrine cells of the intestinal epithelium (so-called L-cells), and in certain neurons of the brain stem. Whereas in the pancreas, glucagon, the hyperglycaemic hormone, is cleaved out of the 160 amino acid precursor, proglucagon, leaving behind ...
openaire +4 more sources
Diabetes, 1998
Proglucagon contains the sequence of two glucagonlike peptides, GLP-1 and GLP-2, secreted from enteroendocrine cells of the small and large intestine. GLP-1 lowers blood glucose in both NIDDM and IDDM patients and may be therapeutically useful for treatment of patients with diabetes.
openaire +3 more sources
Proglucagon contains the sequence of two glucagonlike peptides, GLP-1 and GLP-2, secreted from enteroendocrine cells of the small and large intestine. GLP-1 lowers blood glucose in both NIDDM and IDDM patients and may be therapeutically useful for treatment of patients with diabetes.
openaire +3 more sources